117 related articles for article (PubMed ID: 8894378)
1. In vivo effect of teicoplanin and vancomycin upon haemolytic and bactericidal activity of serum against Staphylococcus aureus.
RodrÃguez AB; Pedrera MI; Barriga C
Comp Immunol Microbiol Infect Dis; 1996 Sep; 19(4):283-8. PubMed ID: 8894378
[TBL] [Abstract][Full Text] [Related]
2. The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus.
van der Broek PJ; Buys LF
J Antimicrob Chemother; 1990 May; 25(5):787-95. PubMed ID: 2142684
[TBL] [Abstract][Full Text] [Related]
3. Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils.
Pedrera MI; Barriga C; Rodriguez AB
Comp Immunol Microbiol Infect Dis; 1995 Feb; 18(2):123-8. PubMed ID: 7621668
[TBL] [Abstract][Full Text] [Related]
4. Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus.
Stanley D; McGrath BJ; Lamp KC; Rybak MJ
Pharmacotherapy; 1994; 14(1):35-9. PubMed ID: 8159599
[TBL] [Abstract][Full Text] [Related]
5. Protein binding and serum bactericidal activities of vancomycin and teicoplanin.
Dykhuizen RS; Harvey G; Stephenson N; Nathwani D; Gould IM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1842-7. PubMed ID: 7486929
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
7. Effect of cefepime (BMY-28142) on the hemolytic and bactericidal activity of serum in vivo and in vitro.
Pedrera MI; Barriga C; Ortega E; RodrÃguez AB
Rev Esp Fisiol; 1994 Sep; 50(3):153-8. PubMed ID: 7886272
[TBL] [Abstract][Full Text] [Related]
8. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
10. In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Bergeret M; Raymond J
J Antimicrob Chemother; 1999 Feb; 43(2):291-4. PubMed ID: 11252338
[TBL] [Abstract][Full Text] [Related]
11. Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.
Lai CC; Chen CC; Chuang YC; Tang HJ
Sci Rep; 2017 Jan; 7():41758. PubMed ID: 28139739
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.
Bailey EM; Rybak MJ; Kaatz GW
Antimicrob Agents Chemother; 1991 Jun; 35(6):1089-92. PubMed ID: 1834010
[TBL] [Abstract][Full Text] [Related]
13. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
[TBL] [Abstract][Full Text] [Related]
14. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
[No Abstract] [Full Text] [Related]
15. Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.
Lagast H; Dodion P; Klastersky J
J Antimicrob Chemother; 1986 Oct; 18(4):513-20. PubMed ID: 2945811
[TBL] [Abstract][Full Text] [Related]
16. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
[TBL] [Abstract][Full Text] [Related]
17. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Carper HT; Sullivan GW; Mandell GL
J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
Maple PA; Hamilton-Miller JM; Brumfitt W
J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of staphylococci to teicoplanin and vancomycin.
Murphy OM; Stewart D; Gray J; Bint AJ
J Antimicrob Chemother; 1996 Aug; 38(2):316-7. PubMed ID: 8877549
[No Abstract] [Full Text] [Related]
20. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
